113 related articles for article (PubMed ID: 25341273)
1. Influence of montelukast on cisplatin-induced experimental acute renal failure.
Teslariu O; Nechifor M; Plămădeală P; Miron IC
Rev Med Chir Soc Med Nat Iasi; 2014; 118(3):612-7. PubMed ID: 25341273
[TBL] [Abstract][Full Text] [Related]
2. Beneficial effects of montelukast against cisplatin-induced acute renal damage in rats.
Beytur A; Köse E; Sarihan ME; Sapmaz HI; Dogan Z; Cetin A; Vardi N; Turkoz Y; Ekinci N
Ren Fail; 2012; 34(3):343-9. PubMed ID: 22260262
[TBL] [Abstract][Full Text] [Related]
3. Oxidative renal damage in pyelonephritic rats is ameliorated by montelukast, a selective leukotriene CysLT1 receptor antagonist.
Tuğtepe H; Sener G; Cetinel S; Velioğlu-Oğünç A; Yeğen BC
Eur J Pharmacol; 2007 Feb; 557(1):69-75. PubMed ID: 17173892
[TBL] [Abstract][Full Text] [Related]
4. Protective effect of montelukast which is cysteinyl-leukotriene receptor antagonist on gentamicin-induced nephrotoxicity and oxidative damage in rat kidney.
Otunctemur A; Ozbek E; Cekmen M; Cakir SS; Dursun M; Polat EC; Somay A; Ozbay N
Ren Fail; 2013; 35(3):403-10. PubMed ID: 23342977
[TBL] [Abstract][Full Text] [Related]
5. Renoprotective effects of montelukast in an experimental model of cisplatin nephrotoxicity in rats.
Gad AM; El-Raouf OMA; El-Sayeh BM; Fawzy HM; Abdallah DM
J Biochem Mol Toxicol; 2017 Dec; 31(12):. PubMed ID: 28902463
[TBL] [Abstract][Full Text] [Related]
6. Chronic renal failure-induced multiple-organ injury in rats is alleviated by the selective CysLT1 receptor antagonist montelukast.
Sener G; Sakarcan A; Sehirli O; Ekşioğlu-Demiralp E; Sener E; Ercan F; Gedik N; Yeğen BC
Prostaglandins Other Lipid Mediat; 2007 Jun; 83(4):257-67. PubMed ID: 17499745
[TBL] [Abstract][Full Text] [Related]
7. The effects of montelukast against amikacin-induced acute renal damage.
Kose E; Beytur A; Dogan Z; Ekincioglu Z; Vardi N; Cinar K; Turkoz Y; Soysal H; Ekinci N
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):503-11. PubMed ID: 22696878
[TBL] [Abstract][Full Text] [Related]
8. Montelukast ameliorates kidney function and urinary bladder sensitivity in experimentally induced renal dysfunction in rats.
Suddek GM
Fundam Clin Pharmacol; 2013 Apr; 27(2):186-91. PubMed ID: 21985664
[TBL] [Abstract][Full Text] [Related]
9. Cysteinyl leukotriene receptor antagonist montelukast ameliorates acute lung injury following haemorrhagic shock in rats.
Al-Amran FG; Hadi NR; Hashim AM
Eur J Cardiothorac Surg; 2013 Feb; 43(2):421-7. PubMed ID: 22851661
[TBL] [Abstract][Full Text] [Related]
10. Magnesium and other bivalent cations influence upon sodium montelukast effect in experimental-induced thermoalgesia.
Nechifor M; Cuciureanu M; Chelarescu D; Ciubotariu D; Pascu M
Magnes Res; 2008 Mar; 21(1):38-42. PubMed ID: 18557132
[TBL] [Abstract][Full Text] [Related]
11. MK-571 attenuates kidney ischemia and reperfusion-induced airway hypersensitivity in rats.
Wu NC; Tong SP; Yang YC; Wang JC; Wang JJ
Transplant Proc; 2014 May; 46(4):1127-30. PubMed ID: 24815144
[TBL] [Abstract][Full Text] [Related]
12. Changes in Some Divalent Cations Concentrations In An Experimental Rat Model of Gentamicin-Induced Acute Renal Failure.
Mititelu-Tarţău L; Teslariu O; Galeş C; Nechifor M
Rev Med Chir Soc Med Nat Iasi; 2016; 120(4):947-52. PubMed ID: 30141892
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of tonapofylline (BG9928), an adenosine A1 receptor antagonist, against cisplatin-induced acute kidney injury in rats.
Gill A; Wortham K; Costa D; Davis W; Ticho B; Whalley E
Am J Nephrol; 2009; 30(6):521-6. PubMed ID: 19828940
[TBL] [Abstract][Full Text] [Related]
14. Effect of rosiglitazone on cisplatin-induced nephrotoxicity.
Ozkaya O; Yavuz O; Can B; Dilek M; Savli E; Acikgoz Y; Bedir A; Akpolat T
Ren Fail; 2010 Jan; 32(3):368-71. PubMed ID: 20370454
[TBL] [Abstract][Full Text] [Related]
15. Role of the poly(ADP-ribose)polymerase activity in vancomycin-induced renal injury.
Dalaklioglu S; Tekcan M; Gungor NE; Celik-Ozenci C; Aksoy NH; Baykal A; Tasatargil A
Toxicol Lett; 2010 Feb; 192(2):91-6. PubMed ID: 19833176
[TBL] [Abstract][Full Text] [Related]
16. Montelukast abrogates rhabdomyolysis-induced acute renal failure via rectifying detrimental changes in antioxidant profile and systemic cytokines and apoptotic factors production.
Helmy MM; El-Gowelli HM
Eur J Pharmacol; 2012 May; 683(1-3):294-300. PubMed ID: 22449377
[TBL] [Abstract][Full Text] [Related]
17. The protective effects of Zhen-Wu-Tang against cisplatin-induced acute kidney injury in rats.
Liu Q; Hu S; He Y; Zhang J; Zeng X; Gong F; Liang L
PLoS One; 2017; 12(6):e0179137. PubMed ID: 28586398
[TBL] [Abstract][Full Text] [Related]
18. Montelukast attenuates side effects of cisplatin including testicular, spermatological, and hormonal damage in male rats.
Beytur A; Ciftci O; Oguz F; Oguzturk H; Yilmaz F
Cancer Chemother Pharmacol; 2012 Jan; 69(1):207-13. PubMed ID: 21681572
[TBL] [Abstract][Full Text] [Related]
19. Nephroprotective efficacy of chrysin against cisplatin-induced toxicity via attenuation of oxidative stress.
Sultana S; Verma K; Khan R
J Pharm Pharmacol; 2012 Jun; 64(6):872-81. PubMed ID: 22571266
[TBL] [Abstract][Full Text] [Related]
20. Renal protective effects of leukotriene receptor blockers in an experimental model of cyclosporine nephrotoxicity.
Atakan A; Arikan H; Macunluoglu B; Tuglular S; Ulfer G; Cakalagaoglu F; Ozener C; Akoglu E
Transplant Proc; 2008; 40(1):279-84. PubMed ID: 18261606
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
